Eslicarbazepine acetate interacts in a beneficial manner with standard and alternative analgesics to reduce trigeminal nociception.
Rationale: Acute pain states in the trigeminal region (headaches, dental pain) fall into the most prevalent painful conditions. Standard analgesics (paracetamol/NSAIDs) represent the cornerstone of their treatment, whereas triptans are primarily used in migraine attacks. Due to limited efficacy and/...
| Published in: | Psychopharmacology Vol. 237; no. 5; pp. 1435 - 1447 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
May2020
|
| Online Access: | View this record in EBSCOhost |